ORTEXORTEX News
Tracking ADI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AD
Trader NoteADI

ADI Options Traders Turn Cautious Ahead of November Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 18:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Analog Devices enters the final stretch before its November 25 earnings with options positioning drifting more defensive, analysts lifting targets after a strong August print, and insiders selling into recent strength.

The clearest signal this week is in options. Put/call ratio has edged up to 0.53, about 1.3 standard deviations above its 20-day average of 0.48. That is not an alarm, but it is the highest reading since mid-September and marks a steady drift toward more protective positioning over the past two weeks. The 52-week high on the PCR is 1.00, so there is plenty of room for the skew to worsen, but the direction of travel is worth noting ahead of a print still 35 days out.

Short interest at 2.0% of free float is low enough that it is not the story here. The borrow market confirms as much: availability is effectively uncapped, with some 483 million shares available against roughly 9.8 million shorted. Cost to borrow has risen about 26% over the past week to 0.46%, but in absolute terms that is still sub-50 basis points, a level that carries no squeeze risk. Short interest itself is down fractionally on the week, after a brief climb through early October that pushed it from around 8.5 million shares toward 10 million before fading. Positioning looks cautious in options, not in the borrow market.

The Street remains broadly constructive. A cluster of upgrades and target raises followed the August 19 results: JP Morgan, Morgan Stanley, Bernstein and others all moved higher, with targets clustering in the $450 to $500 range. The most recent action came Monday, when TD Cowen raised its target to $475 from $460 while holding its Buy rating. The consensus mean target is $472, roughly 19% above the current price of $397. One outlier worth flagging is a Baird target of $675 set in late August, which sits well above the pack and may reflect a different modeling assumption; the $472 consensus is the more representative read. The bull case centres on ADI's positioning in AI datacenter power and optical infrastructure, where management has described a total addressable market they now see as twice as large as estimated earlier in the year. The bear case centres on analog cyclicality, growing Chinese capacity, and the question of whether channel restocking has actually begun despite days-inventory-outstanding falling to 156 days.

Factor scores fill out the picture. The dividend score ranks in the 97th percentile, reflecting a long history of consistent payments, though the most recent dividend data in the snapshot is stale and the current yield should be verified independently. The days-to-cover rank is high at 81, consistent with the low short interest. EPS momentum over 30 and 90 days is roughly neutral, ranking at 44 and 50 respectively, which fits with a stock that has already run about 45% year-to-date and is pausing for breath. Valuation is moderate: PE near 25x and EV/EBITDA around 19x, both little changed over the past month.

Insider activity has been one-directional. The COO, Vivek Jain, sold approximately $2.2 million worth of stock in two open-market transactions on October 7 and 8, at prices in the $407 to $410 range. Those were discretionary sales, not under a 10b5-1 plan. Director Ray Stata executed a series of smaller pre-planned sales on the same day totalling around $577,000, all under a 10b5-1 arrangement and therefore lower signal. Net insider selling over the past 90 days amounts to roughly $17.2 million across 44,700 shares. With the stock up sharply this year, the level of selling is not unusual for a large-cap semiconductor name at these prices, but there have been no offsetting purchases.

The week's 4.3% decline brought ADI roughly in line with peers: MCHP gained 2.3%, TXN fell 3.5%, MPWR dropped 5.4%, and DIOD fell 5.9%. The relative performance is modest outperformance against the weaker names in the group. The prior earnings event on August 19 produced a 1.7% decline on the day and a 1.3% five-day loss, a muted reaction to what appeared to be an above-consensus result. The November 25 date, the insider sales, and the modest drift in options positioning are the data points worth tracking from here.

Stocks in this article

See the live data behind this article on ORTEX.

Open ADI on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:07
Data as of
21 Oct 2026, 18:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.